Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
7,464,711
-
Share change
-
+448,085
-
Total reported value
-
$132,122,000
-
Price per share
-
$17.70
-
Number of holders
-
23
-
Value change
-
+$7,983,334
-
Number of buys
-
13
-
Number of sells
-
15
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2015
As of 30 Sep 2015,
Ascendis Pharma A/S - ADR (ASND) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,464,711 shares.
The largest 10 holders included
Visium Asset Management, LP, FMR LLC, RS INVESTMENT MANAGEMENT CO LLC, VHCP Management, LLC, JANUS CAPITAL MANAGEMENT LLC, Longwood Capital Partners LLC, BAKER BROS. ADVISORS LP, Rock Springs Capital Management LP, Sio Capital Management, LLC, and ORBIMED ADVISORS LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.